HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 2 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $614,000 | +47.2% | 18,706 | +58.0% | 0.00% | – |
| Q2 2023 | $417,000 | +64.2% | 11,837 | +52.3% | 0.00% | – |
| Q1 2023 | $254,000 | -56.0% | 7,774 | -25.8% | 0.00% | – |
| Q4 2022 | $577,000 | +124.5% | 10,479 | +80.7% | 0.00% | – |
| Q3 2022 | $257,000 | +542.5% | 5,800 | +609.9% | 0.00% | – |
| Q2 2022 | $40,000 | -63.3% | 817 | -63.6% | 0.00% | – |
| Q1 2022 | $109,000 | -47.1% | 2,242 | -53.7% | 0.00% | – |
| Q4 2021 | $206,000 | +64.8% | 4,843 | +48.7% | 0.00% | – |
| Q3 2021 | $125,000 | +92.3% | 3,257 | +42.0% | 0.00% | – |
| Q2 2021 | $65,000 | +195.5% | 2,293 | +242.2% | 0.00% | – |
| Q1 2021 | $22,000 | +1000.0% | 670 | +1096.4% | 0.00% | – |
| Q4 2020 | $2,000 | – | 56 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |